Journal of Medicinal Chemistry p. 1421 - 1426 (1987)
Update date:2022-08-03
Topics:
Bandurco, Victor T.
Schwender, Charles F.
Bell, Stanley C.
Combs, Donald W.
Kanojia, Ramesh M.
et al.
The synthesis, cardiac fraction III cyclic nucleotide phosphodiesterase (PDE-III) inhibition, and positive inotropic activity of a series of 2(1H)-quinazolinones are reported.A general synthesis of the series involved the cyclization of 2-aminoacetophenones with potassium cyanate in acetic acid.Modifications at the 4-position of the quinazoline nucleus were best achieved by formation of the intermediate N1-acyl-N3-phenylurea from the substituted phenyl isocyanate and appropriate carboxamide.PPA was used to ring close to the quinazoline product.Generally the SAR for the series paralleled the five-point model previously published for PDE-III inhibition.The most active analogue of the series was 5,6-dimethoxy-4-methyl-2(1H)-quinazolinone (1) (ORF 16600), which had about twice the intravenous potency of amrinone.Compound 1 is currently under development as an orally active cardiotonic.
View MoreShandong Dayi Chemical Co., Ltd.
website:http://www.dayi.com.cn
Contact:+86- 535-7388728. 15306386031
Address:No 1 Danya west road, Laiyang City, Shandong province
Dongtai Xinyuan Chemical Co., Ltd.
Contact:+86-21-56733000
Address:404F, 99Nong No.117 Zhongtan Rd. Shanghai
jiangsu senxuan pharmaceutical and chemical co.,ltd
Contact:86-523-87982810
Address:hongqiao industrial zone,taixing,jiangsu china
Xinjiang Fufeng Biotechnologies Co., Ltd.
Contact:+86-539-7287111
Address:GANQUANPU INDUSTRIAL PARK, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT AREA (TOUTUNHE DISTRICT) OF URUMQI
website:http://www.sdowchem.com
Contact:86-135-2193 7483
Address:8-106 taiyue building
Doi:10.1002/zaac.200700207
(2007)Doi:10.1021/ja01526a067
(1959)Doi:10.1002/chem.200801024
(2008)Doi:10.1016/j.tetlet.2008.09.028
(2008)Doi:10.1016/S0040-4039(97)00569-8
(1997)Doi:10.1016/S0960-894X(01)00154-8
(2001)